Genentech, a member of the Roche Group (SIX: RO, ROP; OTCQX: RHHBY), announced today that it will present new data from its Alzheimer’s disease portfolio at the Alzheimer’s Association International ...
Five oral presentations in a Featured Research Session will highlight trontinemab, including new long-term data from Phase Ib ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results